Vertex Pharmaceuticals Misses Sales Estimates in Q3 Due to CF Treatment Demand

Vertex Pharmaceuticals Misses Sales Estimates in Q3 Due to CF Treatment Demand

Vertex Pharmaceuticals missed sales estimates for the third quarter, with a 35.4% decline in sales of its older cystic fibrosis…

Read More »